Osteopore Ltd
OSX
Company Profile
Business description
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Contact
2 Tukang Innovation Grove
No. 09-06 and 07, JTC MedTech Hub
Singapore618305
SGPSector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
stocks
Why ANZ changes aren’t just about cutting costs
The banking major needs to prevent key product offerings from falling further behind the competition.
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,095.20 | 28.80 | 0.32% |
| CAC 40 | 7,774.26 | 24.87 | 0.32% |
| DAX 40 | 23,708.39 | 10.06 | -0.04% |
| Dow JONES (US) | 45,636.66 | 74.68 | -0.16% |
| FTSE 100 | 9,236.99 | 5.54 | -0.06% |
| HKSE | 26,200.26 | 262.13 | 1.01% |
| NASDAQ | 21,956.48 | 77.00 | 0.35% |
| Nikkei 225 | 43,837.67 | 378.38 | 0.87% |
| NZX 50 Index | 13,276.24 | 22.51 | 0.17% |
| S&P 500 | 6,543.77 | 31.16 | 0.48% |
| S&P/ASX 200 | 8,830.40 | 40.00 | 0.46% |
| SSE Composite Index | 3,812.22 | 4.93 | 0.13% |